The Drug Shortage Prevention Act of 2025 aims to improve the notification process for manufacturers of critical drugs when there is an increase in demand or any disruption in supply. The main goal is to prevent drug shortages that can affect patient care and public health. Key provisions of this law require drug manufacturers to inform the Secretary of Health and Human Services about any permanent discontinuation or interruption in the production of critical drugs. This includes notifying the Secretary about increased demand or any other circumstances that might lead to a shortage.